Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/Hyaluronic Acid in Children
2008

Endoscopic Treatment of Vesicoureteral Reflux in Children

Sample size: 1200 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wolfgang H. Cerwinka, Hal C. Scherz, Andrew J. Kirsch

Primary Institution: Children's Healthcare of Atlanta, Emory University School of Medicine

Hypothesis

Endoscopic treatment for vesicoureteral reflux (VUR) in children is effective and may be preferable to traditional surgical methods.

Conclusion

Endoscopic injection is emerging as the treatment of choice for VUR in children.

Supporting Evidence

  • Most contemporary series report cure rates of greater than 85% for primary VUR.
  • Endoscopic treatment offers major advantages to patients while avoiding potentially complicated open surgery.
  • Endoscopic injection has been successfully employed in patients who either failed ureteral reimplantation or initial injection.

Takeaway

Doctors can fix a problem in kids' bladders without big surgery by using a special gel that helps stop urine from going the wrong way.

Methodology

The review summarizes current indications, injectable agents, techniques, success rates, complications, and future applications of endoscopic treatment for VUR.

Potential Biases

Potential bias in reporting success rates due to varying follow-up lengths and definitions of success.

Limitations

Success rates may vary based on different inclusion criteria and definitions of success across studies.

Participant Demographics

Children diagnosed with vesicoureteral reflux.

Digital Object Identifier (DOI)

10.1155/2008/513854

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication